Stematix Obtains Exclusive License to Regenexx Stem Cell Procedure Treating Musculoskeletal Disorders in Latin America |

Stematix Obtains Exclusive License to Regenexx Stem Cell Procedure Treating Musculoskeletal Disorders in Latin America

Stematix

 

 

Stematix Inc., announced today it has signed an exclusive royalty-bearing license agreement, for the Latin American territory, to use an innovative process that rapidly grows a patients own adult stem cells to treat a variety of musculoskeletal diseases.

http://ow.ly/wuCl

Leave a Reply

Your email address will not be published. Required fields are marked *